Galectin Therapeutics Inc $5.22

up +0.36


22/8/2014 04:00 PM  |  NASDAQ : GALT  
Industries : Drugs / Drugs - Generic
Get Trend Analysis Icon Get GALT Trend Analysis - it has underperformed the S&P 500 by 41%

Partner Headlines

  1. UPDATE: Aegis Capital Downgrades Galectin Therapeutics

    Benzinga
  2. Galectin Issues Statement on Yesterday's Sell Off, Says Attributed To Negative ...

    Benzinga
  3. Morning Market Losers

    Benzinga
  4. Galectin Offers Results in Preclinical Model of GR-MD-02, Results Show ...

    Benzinga
  5. Galectin Therapeutics Completes Enrollment of Second Cohort of Phase 1 ...

    Benzinga
  6. Galectin Therapeutics Announces First Patient Dosed in Second Cohort of ...

    Benzinga
  7. MLV & Co Expects Positive News from Galectin Therapeutics

    Benzinga
  8. Benzinga's Volume Movers

    Benzinga
  9. Fatty Liver Disease Should Keep Stocks Moving In 2014

    IBD
  10. Galectin Therapeutics Complet Enrollment in First Cohort of Phase 1 Trial ...

    Benzinga
  11. Market Wrap For January 10: Job Growth Weak, But Unemployment Falls

    Benzinga
  12. Benzinga's Volume Movers

    Benzinga
  13. Galectin Announces Early Warrant Exercise by 10X Fund, Issues Update on ...

    Benzinga
  14. UPDATE: Ascendiant Capital Initiates Coverage on Galectin Therapeutics ...

    Benzinga
  15. Benzinga's Top Initiations

    Benzinga
  16. Benzinga's Volume Movers

    Benzinga
  17. Morning Market Movers

    Benzinga
  18. Benzinga's Volume Movers

    Benzinga
  19. UPDATE: Aegis Capital Raises PT on Galectin Therapeutics Following Valuation ...

    Benzinga
  20. Morning Market Movers

    Benzinga
  21. Galectin Therapeutics Reports FDA Fast Track Designation for GR-MD-02

    Benzinga
  22. Galectin Therapeutics Says Anti-Galectin Drug Effective in Preclinical ...

    Benzinga
  23. Galectin Therapeutics Names Shlevin COO

    Benzinga
  24. Galectin Therapeutics Receives U.S. Patent for Potential Ground-Breaking ...

    Benzinga
  25. UPDATE: Dawson James Reiterates Buy Rating, Lowers PT on Galectin Therapeutics

    Benzinga
  26. ProShares Trust Ultra VIX Short Term Futures ETF, CTC Media Among Stocks ...

    FoxBusiness
Trading Center